PrognoCIS EHR Successfully Deploys MACRA Certified Product To Its Customer Base

Share Article

Medical practices can fulfill their reporting requirements under the Quality Payment Program (QPP) and receive a positive payment adjustment for 2017 using PrognoCIS EHR.

Bizmatics, Inc. is proud to announce that it officially completed MACRA certification, and has deployed the updates across its customer base.

To receive a positive MIPS payment, medical practices must submit 90 days (the deadline to begin is October 2, 2017) of continuous data for three categories: Advancing Care Information (ACI), Quality, and Improvement Activities. With the new upgrades, physicians can collect data on any of the 74 claims-based measures under the Quality category. They can also meet their minimum requirements for ACI with the 15 measures supported in PrognoCIS.

Physicians should visit the QPP website to determine their participation status. Medical practitioners who treat more than 100 Medicare patients, or have over $30,000 in Medicare claims will be required to participate in MIPS. We encourage all medical practitioners who qualify for the QPP and are using PrognoCIS EHR to contact us immediately in order to begin upgrades and training.

“PrognoCIS was designed to meet the needs of the medical practice to capture, retrieve, and process data in today’s fast-paced healthcare environment,” says Vinay Deshpande, CEO of Bizmatics. “Now that PrognoCIS is a MACRA-certified product, our doctors are well-positioned to receive their reimbursements, avoid penalties, and are eligible for positive incentives for 2017 and beyond.”

About Bizmatics:
Bizmatics, Inc. is the developer of PrognoCIS electronic health records software, which has provided clinical and business productivity suites and services to the healthcare providers market since 2002. The PrognoCIS application serves over 15,000 medical professionals and has facilitated over 25,000,000 patient interactions. Bizmatics is headquartered in San Jose, California.

Learn more at, or follow PrognoCIS on twitter: @PrognoCIS

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Apoorva Anupindi
+1 408.873.3030 Ext: 211
Email >
Follow >
Like >
Follow us on
Visit website